Beacon Investment Advisory Services Inc. Sells 58,696 Shares of Kenvue Inc. $KVUE

Beacon Investment Advisory Services Inc. cut its stake in Kenvue Inc. (NYSE:KVUE) by 12.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 408,412 shares of the company’s stock after selling 58,696 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Kenvue were worth $7,045,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. CIBRA Capital Ltd acquired a new stake in Kenvue in the 4th quarter valued at $2,139,000. Global X Japan Co. Ltd. raised its stake in Kenvue by 37.7% during the fourth quarter. Global X Japan Co. Ltd. now owns 38,579 shares of the company’s stock worth $665,000 after acquiring an additional 10,557 shares in the last quarter. Mather Group LLC. lifted its holdings in shares of Kenvue by 122.8% during the fourth quarter. Mather Group LLC. now owns 67,206 shares of the company’s stock valued at $1,159,000 after acquiring an additional 37,037 shares during the period. Butensky & Cohen Financial Security Inc. lifted its holdings in shares of Kenvue by 4.5% during the fourth quarter. Butensky & Cohen Financial Security Inc. now owns 223,228 shares of the company’s stock valued at $3,851,000 after acquiring an additional 9,704 shares during the period. Finally, Norden Group LLC acquired a new stake in shares of Kenvue in the 4th quarter valued at $689,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on KVUE. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and lowered their target price for the stock from $23.00 to $18.00 in a report on Friday, January 30th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Barclays raised their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Finally, UBS Group lifted their target price on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $19.58.

Kenvue Trading Down 0.0%

KVUE opened at $17.52 on Monday. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The stock has a market capitalization of $33.57 billion, a PE ratio of 22.75, a PEG ratio of 3.98 and a beta of 0.51. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $18.01 and a two-hundred day moving average price of $17.12.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period in the prior year, the business earned $0.26 earnings per share. Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.